Epigral Q4 Results: Profit Rs 82 Cr, Revenue Rs 736 Cr

Mumbai, May 4 (PTI) Epigral Ltd has reported a net profit of Rs 82 crore for the January-March quarter of 2025-26, down by nearly 6 per cent compared to Rs 87 crore in the year-ago period, a statement said on Monday.

The company, however, reported a 17 per cent jump in revenue to Rs 736 crore, its highest in a quarter, for the January-March period of FY26 against Rs 631 crore in Q4 of FY25, the company said in a statement.

Sequentially, profit soared more than two-fold compared to Rs 39 crore and revenue jumped 22 per cent from Rs 603 crore in the December quarter of FY26.


Epigral Chairman and Managing Director Maulik Patel said, "In Q4 FY26, we delivered record revenue of Rs 736 crore, driven by a 15 per cent sequential increase and 14 per cent year-on-year growth in volumes.

"This performance reflects strong demand conditions and a full recovery post-scheduled maintenance in Q3. Improved utilisation levels and stabilisation in raw material costs supported EBITDA margins of 23 per cent.

The company said its board has approved a final dividend of Rs 5 per share for FY26.

Shares of the integrated chemical manufacturer jumped more than 10 per cent to settle at Rs 1,329.45 on BSE on Monday after the financial results.